202 related articles for article (PubMed ID: 17143786)
21. IDF and ATP-III definitions of metabolic syndrome in the prediction of all-cause mortality in type 2 diabetic patients.
Monami M; Marchionni N; Masotti G; Mannucci E
Diabetes Obes Metab; 2007 May; 9(3):350-3. PubMed ID: 17391162
[TBL] [Abstract][Full Text] [Related]
22. Frequency of metabolic syndrome among hemodialysis patients according to NCEP-ATP III and IDF definitions.
Ucar E; Huzmeli C; Guven O; Savas N; Gullu M; Asilyoruk S; Kuvandik C; Temizkan A; Kuvandik G
Ren Fail; 2009; 31(3):221-8. PubMed ID: 19288328
[TBL] [Abstract][Full Text] [Related]
23. Prevalence of metabolic syndrome in urban Pakistan (Karachi): comparison of newly proposed International Diabetes Federation and modified Adult Treatment Panel III criteria.
Hydrie MZ; Shera AS; Fawwad A; Basit A; Hussain A
Metab Syndr Relat Disord; 2009 Apr; 7(2):119-24. PubMed ID: 18928398
[TBL] [Abstract][Full Text] [Related]
24. Prevalence of the metabolic syndrome among Korean adults using the new International Diabetes Federation definition and the new abdominal obesity criteria for the Korean people.
Kim HM; Kim DJ; Jung IH; Park C; Park J
Diabetes Res Clin Pract; 2007 Jul; 77(1):99-106. PubMed ID: 17118477
[TBL] [Abstract][Full Text] [Related]
25. Prevalence of metabolic syndrome in Nakhon Sawan population.
Santibhavank P
J Med Assoc Thai; 2007 Jun; 90(6):1109-15. PubMed ID: 17624204
[TBL] [Abstract][Full Text] [Related]
26. A comparison of the new international diabetes federation definition of metabolic syndrome to WHO and NCEP definitions in Chinese, European and South Asian origin adults.
Unwin N; Bhopal R; Hayes L; White M; Patel S; Ragoobirsingh D; Alberti G
Ethn Dis; 2007; 17(3):522-8. PubMed ID: 17985508
[TBL] [Abstract][Full Text] [Related]
27. Cardiometabolic risk in polycystic ovary syndrome: a comparison of different approaches to defining the metabolic syndrome.
Cussons AJ; Watts GF; Burke V; Shaw JE; Zimmet PZ; Stuckey BG
Hum Reprod; 2008 Oct; 23(10):2352-8. PubMed ID: 18635531
[TBL] [Abstract][Full Text] [Related]
28. Hyperhomocysteinemia, coronary heart disease, and diabetes mellitus as predicted by various definitions for metabolic syndrome in a hypertensive Saudi population.
Al-Daghri NM
Saudi Med J; 2007 Mar; 28(3):339-46. PubMed ID: 17334456
[TBL] [Abstract][Full Text] [Related]
29. Impact of insulin resistance on risk of type 2 diabetes and cardiovascular disease in people with metabolic syndrome.
Meigs JB; Rutter MK; Sullivan LM; Fox CS; D'Agostino RB; Wilson PW
Diabetes Care; 2007 May; 30(5):1219-25. PubMed ID: 17259468
[TBL] [Abstract][Full Text] [Related]
30. Prevalence of metabolic syndrome at age 16 using the International Diabetes Federation paediatric definition.
Pirkola J; Tammelin T; Bloigu A; Pouta A; Laitinen J; Ruokonen A; Tapanainen P; Järvelin MR; Vääräsmäki M
Arch Dis Child; 2008 Nov; 93(11):945-51. PubMed ID: 18456683
[TBL] [Abstract][Full Text] [Related]
31. Prevalence of metabolic syndrome in the Mediterranean region of Turkey: evaluation of hypertension, diabetes mellitus, obesity, and dyslipidemia.
Gündogan K; Bayram F; Capak M; Tanriverdi F; Karaman A; Ozturk A; Altunbas H; Gökce C; Kalkan A; Yazici C
Metab Syndr Relat Disord; 2009 Oct; 7(5):427-34. PubMed ID: 19754305
[TBL] [Abstract][Full Text] [Related]
32. Epidemiology of metabolic syndrome in Asia.
Pan WH; Yeh WT; Weng LC
Asia Pac J Clin Nutr; 2008; 17 Suppl 1():37-42. PubMed ID: 18296297
[TBL] [Abstract][Full Text] [Related]
33. The reliability of the National Cholesterol Education Program's Adult Treatment Panel III (NCEP/ATP III) and the International Diabetes Federation (IDF) definitions in diagnosing metabolic syndrome (MetS) among Gaza Strip Palestinians.
Sirdah MM; Abu Ghali AS; Al Laham NA
Diabetes Metab Syndr; 2012; 6(1):4-8. PubMed ID: 23014247
[TBL] [Abstract][Full Text] [Related]
34. Prevalence of undiagnosed metabolic syndrome in a population of adult asymptomatic subjects.
Bo S; Ciccone G; Pearce N; Merletti F; Gentile L; Cassader M; Pagano G
Diabetes Res Clin Pract; 2007 Mar; 75(3):362-5. PubMed ID: 16930757
[TBL] [Abstract][Full Text] [Related]
35. A comparison of the prevalence of the MS and its complications using three proposed definitions in Korean subjects.
Sung KC; Kim BJ; Kim BS; Lee WY; Park JB; Wilson AM
Am J Cardiol; 2009 Jun; 103(12):1732-5. PubMed ID: 19539084
[TBL] [Abstract][Full Text] [Related]
36. The impact of central obesity as a prerequisite for the diagnosis of metabolic syndrome.
Khoo CM; Liew CF; Chew SK; Tai ES
Obesity (Silver Spring); 2007 Jan; 15(1):262-9. PubMed ID: 17228055
[TBL] [Abstract][Full Text] [Related]
37. Prognostic impact of metabolic syndrome by different definitions in a population with high prevalence of obesity and diabetes: the Strong Heart Study.
de Simone G; Devereux RB; Chinali M; Best LG; Lee ET; Galloway JM; Resnick HE;
Diabetes Care; 2007 Jul; 30(7):1851-6. PubMed ID: 17440172
[TBL] [Abstract][Full Text] [Related]
38. Is a unified definition of metabolic syndrome needed? Comparison of three definitions of metabolic syndrome in 60-year-old men and women.
Carlsson AC; Wändell PE; Halldin M; de Faire U; Hellénius ML
Metab Syndr Relat Disord; 2009 Jun; 7(3):231-41. PubMed ID: 19284315
[TBL] [Abstract][Full Text] [Related]
39. Prevalence of metabolic syndrome among human immunodeficiency virus-infected subjects is widely influenced by the diagnostic criteria.
Cubero JM; Domingo P; Sambeat M; Ordoñez-Llanos J; Rodriguez-Espinosa J; Sánchez-Quesada JL; Pérez A
Metab Syndr Relat Disord; 2011 Oct; 9(5):345-51. PubMed ID: 21542770
[TBL] [Abstract][Full Text] [Related]
40. Metabolic syndrome: prevalence, associated factors, and C-reactive protein: the MADRIC (MADrid RIesgo Cardiovascular) Study.
Martínez MA; Puig JG; Mora M; Aragón R; O'Dogherty P; Antón JL; Sánchez-Villares T; Rubio JM; Rosado J; Torres R; Marcos J; Pallardo LF; Banegas JR;
Metabolism; 2008 Sep; 57(9):1232-40. PubMed ID: 18702949
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
